Medical Devices Series B Investors & VC Firms
660 firms in this list, with a median first check of $730K. 140 of them lead rounds. Generated from verified public data and updated continuously.
Nimbus Ventures
ZeistSeries A–Growth
2 people
Strategic Investment Partners Inc.
TokyoPre-Seed–Growth
2 people
Cathay Health
San FranciscoSeed–Late Stage
1 person
BDC Life Sciences Venture Fund
MontrealPre-Seed–Growth
2 people
KSP, Inc.
KawasakiPre-Seed–Growth
1 person
SBI Investment
TokyoPre-Seed–Growth$2M – $227M
1 person
Aurum Ventures MKI
Ramat GanSeed–Late Stage
8 people
Trans-Pacific Technology Fund
TaipeiSeed–Late Stage
8 people
Ambix Venture Management, Llc
Mountain ViewPre-Seed–Late Stage
2 people
Ellis Capital
AtlantaSeed–Growth
2 people
Gilmartin Capital LLC
LarkspurSeries A–Late Stage
2 people
MB Venture Partners
MemphisPre-Seed–Late Stage
2 people
New Age Ventures
New YorkPre-Seed–Series B
2 people
StarChain Ventures
Silicon ValleyPre-Seed–Series B
2 people
NJF Capital
LondonSeed–Late Stage
1 person
WERU Investment Co. Ltd.
TokyoPre-Seed–Growth
1 person
adMare BioInnovations
VancouverPre-Seed–Series B
venture / science
San Francisco Bay AreaSeed–Late Stage
1 person
ABICO Asia Capital Corporation
TaipeiSeed–Late Stage
1 person
Bird B. AG
SchaffhausenSeed–Growth
1 person
CCV Capital
BeijingSeed–Series B
1 person
Dellin Investments
PhiladelphiaPre-Seed–Growth
5 people
Hokkaido Venture Capital, Inc.
SapporoPre-Seed–Late Stage
1 person
Lundbeckfonden Ventures
CopenhagenPre-Seed–Late Stage
1 person
Related lists
Series B Investors & VC Firms (4094)Series B Investors & VC Firms in United States (1625)Medical Devices Investors & VC Firms (1393)SaaS Series B Investors & VC Firms (1317)Series B Investors & VC Firms in Global (1265)Enterprise Software Series B Investors & VC Firms (1242)Healthtech Series B Investors & VC Firms (1216)Medical Devices Seed Investors & VC Firms (1155)Medical Devices Series A Investors & VC Firms (1145)Fintech Series B Investors & VC Firms (1141)
Data sourced from public filings and firms' own websites — see our methodology.

















